Chris Pasquale

“Wally, I also wanted to ask about the enhanced de novo trials. The CHOPS program seems to be a great addition to the portfolio, but previously you were comparing OCS to established hypothermic organ storage approaches in those studies.”

“Besides all the moving pieces you guys had going on, there was also quite a bit of severe weather during the quarter. These cases are reschedulable if the need arises.”

“I had a couple of questions, one on fertility. You talked about improving cycles in the U.S. and Europe. You didn't mention China, which I think was a big piece of the weakness last year.”

“It looks like handpiece sales exceeded procedure volumes by a little over 10,000 units over the past three years, including this quarter's drawdown. So, what gives you confidence that the ratio is going to be one-to-one in 26?”

“Throughout the year, could you just get level set us on how we should think about it here. Is 2Q the low point and then you improve from there and sort of magnitude of the high and the low for the year would be helpful?”